The specific objectives of the Clinical Research Support Services (CRSS) Core are: ? To increase the quality and quantity of investigator-initiated clinical trials and facilitate the translational research efforts of the Cancer Center by providing assistance in protocol development, implementation and data capture. ? To increase the quality and quantity of grants and protocols in population research of the Cancer Center by providing assistance in study design, development of survey tools and recruitment. ? To provide a central core of personnel with expertise in all types of clinical trials management: regulatory;compliance, medical editing, and data management for investigator-initiated clinical intervention trials in cancer prevention, early detection and treatment and observational or epidemiology research relevant to cancer. ? To train and educate clinical research coordinators (data managers and nurses) in clinical intervention trials. ? To train and educate data managers and staff who conduct population-based research. ? To perform internal audits for data and safety monitoring. ? To increase the participation of subjects in clinical trials, with emphasis on diversity. ? -To provide a web-based protocol/data management system for all types of studies. ? To provide the infrastructure for the reporting requirements designated by the NCI. The Clinical Research Support Services Core serves four UCSF campuses: the in-patient and out-patient facilities at Mt. Zion and Parnassus, San Francisco General Hospital and San Francisco Veterans Administration Medical Center.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA082103-12
Application #
8133059
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2010-06-01
Budget End
2011-05-31
Support Year
12
Fiscal Year
2010
Total Cost
$826,514
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Phillips, Kathryn A (2018) Evolving Payer Coverage Policies on Genomic Sequencing Tests: Beginning of the End or End of the Beginning? JAMA 319:2379-2380
Puri, Sapna; Roy, Nilotpal; Russ, Holger A et al. (2018) Replication confers ? cell immaturity. Nat Commun 9:485
An, Zhenyi; Aksoy, Ozlem; Zheng, Tina et al. (2018) Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies. Oncogene 37:1561-1575
Behr, Spencer C; Villanueva-Meyer, Javier E; Li, Yan et al. (2018) Targeting iron metabolism in high-grade glioma with 68Ga-citrate PET/MR. JCI Insight 3:
Rubenstein, James L; Geng, Huimin; Fraser, Eleanor J et al. (2018) Phase 1 investigation of lenalidomide/rituximab plus outcomes of lenalidomide maintenance in relapsed CNS lymphoma. Blood Adv 2:1595-1607
An, Zhenyi; Knobbe-Thomsen, Christiane B; Wan, Xiaohua et al. (2018) EGFR Cooperates with EGFRvIII to Recruit Macrophages in Glioblastoma. Cancer Res 78:6785-6794
Olshen, Adam; Wolf, Denise; Jones, Ella F et al. (2018) Features of MRI stromal enhancement with neoadjuvant chemotherapy: a subgroup analysis of the ACRIN 6657/I-SPY TRIAL. J Med Imaging (Bellingham) 5:011014
Li, Megan; Kroetz, Deanna L (2018) Bevacizumab-induced hypertension: Clinical presentation and molecular understanding. Pharmacol Ther 182:152-160
Brunner, Katja; John, Constance M; Phillips, Nancy J et al. (2018) Novel Campylobacter concisus lipooligosaccharide is a determinant of inflammatory potential and virulence. J Lipid Res 59:1893-1905
Felix, Janine F; Joubert, Bonnie R; Baccarelli, Andrea A et al. (2018) Cohort Profile: Pregnancy And Childhood Epigenetics (PACE) Consortium. Int J Epidemiol 47:22-23u

Showing the most recent 10 out of 192 publications